US Stock MarketDetailed Quotes
XFOWW X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B
- 0.012
- 0.0000.00%
15min DelayClose Aug 13 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.012Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.01252wk High0.00P/B0Float Cap0.01252wk Low--Dividend TTM0Shs Float0.012Historical High--Div YieldTTM0.00%Amplitude0.012Historical Low--Avg Price1Lot Size
X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B Key Stats
EPS
According to the latest financial report of X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B's free cash flow? The latest report shows it as -34.12M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B shows that the company's current ratio is 4.89, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B, the quick ratio is 4.65, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B? The latest ROE figure is -47.63%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B, the total asset return on investment (ROA) is -18.88%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B's latest financial report to see how their gross margin is doing - currently at 59.46%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of X4 PHARMACEUTICALS INC C/WTS 29/11/2024(TO PUR COM) CL B, the net profit margin is -6.55K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data